{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:48:18Z","timestamp":1793274498004,"version":"4.5.0"},"reference-count":239,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Icelandic Research Fund, Icelandic Cancer Society Research Fund, and University of Iceland Research Fund","award":["217946-051"],"award-info":[{"award-number":["217946-051"]}]},{"DOI":"10.13039\/100007904","name":"Texas A and M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sexual dimorphism is a fundamental characteristic of the anatomy and physiology of animals and humans, yet biomedical research has largely ignored these phenomena in the study of health and disease, despite early studies in the eighteenth and nineteenth centuries that demonstrated the importance of sex differences. With the explosive growth of biomedical research following World War II, especially in the 1970s through the 1990s, preclinical and clinical studies led to a greater recognition of sex differences in physiological function, particularly the significant disparities in the incidence of and mortality from cardiovascular diseases, which generally occur more frequently in men than in premenopausal women. There is a growing awareness that metabolic and immune dysfunction are intimately tied to the development of cardiovascular diseases. Thus, this review article focuses on sexual dimorphism in cardiovascular, metabolic, and immune function in health and disease, and was prepared for the journal\n                    <jats:italic>Biology of Sex Differences<\/jats:italic>\n                    as part of its recognition of \u201cSex Differences in Health Awareness Day.\u201d This article clearly reveals the striking importance of sex differences in cardiovascular, metabolic, and immune system functions in health and in the pathogenesis of disease processes, which likely involve a combination of effects of the sex chromosomes as well as the gonadal steroid hormones. In the developing fetus, fetal sex clearly influences the pathogenesis of the hypertensive diseases of pregnancy, and sex differences in the effects of the fetus continue beyond pregnancy and appear to influence the future risk of maternal cardiometabolic diseases. Similarly, there is strong evidence of many clinically-relevant sexually dimorphic characteristics of obesity and type 2 diabetes mellitus which appear to involve both chromosomal and humoral effects, although the underlying pathophysiological mechanisms are poorly understood. The gonadal steroid hormones (both androgens and estrogens) are known to exert important effects on the regulation of intermediary metabolism; however, recent studies reveal the emerging importance of these hormones in the regulation of inflammation. For example, menopausal declines in estrogen are associated with increases in inflammatory markers and the development of heart failure in women. Similar effects on inflammatory function may also occur in men with progressive age-dependent declines in testosterone. Declines in androgen levels in men are also associated with detrimental effects on cardiovascular and metabolic function, especially the development of metabolic syndrome and type 2 diabetes, important risk factors for cardiovascular disease. Interestingly, pathophysiological increases in the normally lower testosterone levels in women are associated with the same detrimental effects on cardiovascular and metabolic function, revealing striking bi-directional sex differences in the effects of the androgens. Finally, it is increasingly apparent that the kidney plays an important role in the regulation of sex steroid hormone levels, and the declines in both estrogen and testosterone that occur with chronic kidney disease appear to play an important role in the linkage between chronic kidney disease and the development of cardiovascular disease. In conclusion. It is clear that sex differences in cardiovascular, metabolic, and immune function play important roles in health and in the pathogenesis of disease. Elucidation of the chromosomal and humoral mechanisms underlying sexual dimorphism in physiological functions will play important roles in the future development of age- and sex-specific prevention and pharmacotherapy of disease processes.\n                  <\/jats:p>","DOI":"10.1186\/s13293-025-00714-7","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T09:35:23Z","timestamp":1747128923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: a review for \u201cSex Differences in Health Awareness Day\u201d"],"prefix":"10.1186","volume":"16","author":[{"given":"Lana","family":"McClements","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kararigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia B.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Stallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"6","key":"714_CR1","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.juro.2007.01.135","volume":"177","author":"NI Miller","year":"2007","unstructured":"Miller NI, Fulmer BR. Injection, ligation, and transplantation: the search for the glandular fountain of youth. J Urol. 2007;177(6):2000\u20135.","journal-title":"J Urol"},{"key":"714_CR2","doi-asserted-by":"crossref","unstructured":"Medvei VC: A history of Endocrinology, MTP Press,1982.","DOI":"10.1007\/978-94-009-7304-6"},{"key":"714_CR3","first-page":"51","volume":"86","author":"C Achard","year":"1921","unstructured":"Achard C, Thiers J. Le virilisme pilaire et son association a l\u2019insuffisance glycolitique (diabete des femmes a barbe). Bull Acad Natl Med Paris. 1921;86:51\u20135.","journal-title":"Bull Acad Natl Med Paris"},{"key":"714_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"20","author":"J Stein","year":"1935","unstructured":"Stein J, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;20:181\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"714_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0039-128X(90)90058-J","volume":"55","author":"MF Kalin","year":"1990","unstructured":"Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids. 1990;55:330\u201352.","journal-title":"Steroids"},{"key":"714_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0002-8703(88)90099-3","volume":"116","author":"D Levy","year":"1988","unstructured":"Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J. 1988;116:266\u201372.","journal-title":"Am Heart J"},{"key":"714_CR7","unstructured":"Kannel WB, Thom TJ: Incidence, prevalence and mortality and cardiovascular disease, in: Schlant RC, Alexander RW (Eds.), The Heart, McGraw-Hill, New York, 1994."},{"key":"714_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7326\/0003-4819-147-3-200708070-00167","volume":"147","author":"EW Gregg","year":"2007","unstructured":"Gregg EW, Gu Q, Cheng YJ, Naranayan KMV, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Int Med. 2007;147:149\u201355.","journal-title":"Ann Int Med"},{"key":"714_CR9","doi-asserted-by":"crossref","unstructured":"WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, DeSimone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, et al:, Heart disease and stroke statistics \u2013 2010 update: a report from the American Heart Association, Circulation 2010, 121: 948-954.","DOI":"10.1161\/CIRCULATIONAHA.109.192666"},{"key":"714_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","volume":"123","author":"L Mosca","year":"2011","unstructured":"Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pi\u00f1a IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D\u2019Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Garcia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn WW, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20132011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243\u201362.","journal-title":"Circulation"},{"key":"714_CR11","volume-title":"Exploring the Biological Contributions to Human Health: Does Sex Matter? Board on Health Sciences Policy, Washington, DC","author":"TM Wizemann","year":"2001","unstructured":"Wizemann TM, Pardue ML. Exploring the Biological Contributions to Human Health: Does Sex Matter? Board on Health Sciences Policy, Washington, DC. USA: Institute of Medicine; 2001."},{"key":"714_CR12","doi-asserted-by":"publisher","first-page":"H453","DOI":"10.1152\/ajpheart.1991.260.2.H453","volume":"260","author":"JN Stallone","year":"1991","unstructured":"Stallone JN, Crofton JT, Share L. Sexual dimorphism in vasopressin-induced contraction of rat aorta. Amer J Physiol, Heart Circ Physiol. 1991;260:H453\u20138.","journal-title":"Amer J Physiol, Heart Circ Physiol"},{"key":"714_CR13","doi-asserted-by":"publisher","first-page":"H2073","DOI":"10.1152\/ajpheart.1993.265.6.H2073","volume":"265","author":"JN Stallone","year":"1993","unstructured":"Stallone JN. Role of endothelium in sexual dimorphism in vasopressin-induced contraction of rat aorta. Amer J Physiol, Heart Circ Physiol. 1993;265:H2073\u201380.","journal-title":"Amer J Physiol, Heart Circ Physiol"},{"key":"714_CR14","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1152\/ajpregu.1995.268.1.R40","volume":"268","author":"JN Stallone","year":"1995","unstructured":"Stallone JN. Sex differences in mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in rats. Am J Physiol, Reg Integ Comp Physiol. 1995;268:R40\u20139.","journal-title":"Am J Physiol, Reg Integ Comp Physiol"},{"key":"714_CR15","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/01.RES.66.5.1345","volume":"66","author":"JT Crofton","year":"1990","unstructured":"Crofton JT, Share L. Sexual dimorphism in vasopressin and cardiovascular response to hemorrhage in the rat. Circ Res. 1990;66:1345\u201353.","journal-title":"Circ Res"},{"key":"714_CR16","doi-asserted-by":"publisher","first-page":"R370","DOI":"10.1152\/ajpregu.1997.272.1.R370","volume":"272","author":"YX Wang","year":"1997","unstructured":"Wang YX, Crofton JT, Share L. Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats. Am J Physiol, Reg Int Comp Physiol. 1997;272:R370\u20136.","journal-title":"Am J Physiol, Reg Int Comp Physiol"},{"key":"714_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/509282a","volume":"509","author":"JA Clayton","year":"2014","unstructured":"Clayton JA. Collins FS:Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509:282\u20133.","journal-title":"Nature"},{"key":"714_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neubiorev.2010.07.002","volume":"35","author":"AK Beery","year":"2011","unstructured":"Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev. 2011;35:565\u201372.","journal-title":"Neurosci Biobehav Rev"},{"key":"714_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2042-6410-2-11","volume":"2","author":"KE Taylor","year":"2011","unstructured":"Taylor KE, Vallejo-Giraldo C, Schaible NS, Zakeri R, Miller VM. Reporting of sex as a variable in cardiovascular studies using cultured cells. Biol Sex Differ. 2011;2:11\u20138.","journal-title":"Biol Sex Differ"},{"key":"714_CR20","doi-asserted-by":"publisher","first-page":"C3","DOI":"10.1152\/ajpcell.00281.2013","volume":"306","author":"K Shah","year":"2014","unstructured":"Shah K, McCormack CE, Bradbury NA. Do you know the sex of your cells? Am J Physiol, Cell Physiol. 2014;306:C3\u201318.","journal-title":"Am J Physiol, Cell Physiol"},{"key":"714_CR21","first-page":"1","volume":"68","author":"I Whitcomb","year":"2025","unstructured":"Whitcomb I. The future of women\u2019s heart health. Physiologist. 2025;68:1\u201310.","journal-title":"Physiologist"},{"issue":"18","key":"714_CR22","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jacc.2023.03.383","volume":"81","author":"M Sawano","year":"2023","unstructured":"Sawano M, Lu Y, Caraballo C, Mahajan S, Dreyer R, Lichtman JH, D\u2019Onofrio GD, Spatz E, Khera R, Onuma O, Murugiah K, Spertus JA, Krumholz HM. Sex Difference in outcomes of acute myocardial infarction in young patients. J Am Coll Cardiol. 2023;81(18):1797\u2013806.","journal-title":"J Am Coll Cardiol"},{"key":"714_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115347","volume":"208","author":"JN Stallone","year":"2023","unstructured":"Stallone JN, Oloyo AK. Cardiovascular and metabolic actions of the androgens: is testosterone a janus-faced molecule? Biochem Pharmacol. 2023;208: 115347.","journal-title":"Biochem Pharmacol"},{"key":"714_CR24","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1016\/S2214-109X(24)00560-6","volume":"13","author":"JA Cresswell","year":"2025","unstructured":"Cresswell JA, Alexander M, Chong MYC, Link HM, Pejchinovska M, Gazeley U, et al. Global and regional causes of maternal deaths 2009\u201320: a WHO systematic analysis. Lancet Glob Heal. 2025;13:e626\u201334.","journal-title":"Lancet Glob Heal"},{"key":"714_CR25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"Hypertension in pregnancy","year":"2013","unstructured":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol [Internet]. 2013;122:1122\u201331.","journal-title":"Obstet Gynecol [Internet]"},{"key":"714_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ajo.12253","volume":"55","author":"SA Lowe","year":"2015","unstructured":"Lowe SA, Bowyer L, Lust K, McMahon LP, Morton MR, North RA, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy, 2014. Aust N Z J Obstet Gynaecol. 2015;55:11\u20136.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"714_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","volume":"13","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & amp management recommendations for international practice. Pregnancy Hypertens. 2018;13:291\u2013310.","journal-title":"Pregnancy Hypertens"},{"key":"714_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1471-0528.2004.00516.x","volume":"112","author":"MA Brown","year":"2005","unstructured":"Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. BJOG An Int J Obstet Gynaecol. 2005;112:601\u20136. https:\/\/doi.org\/10.1111\/j.1471-0528.2004.00516.x.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"714_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"key":"714_CR30","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/j.1471-0528.1998.tb09971.x","volume":"105","author":"P Saudan","year":"1998","unstructured":"Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? BJOG An Int J Obstet Gynaecol. 1998;105:1177\u201384.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"714_CR31","doi-asserted-by":"publisher","unstructured":"Gestational Hypertension and Preeclampsia, Obstet Gynecol 2020,135: e237\u2013e260. https:\/\/doi.org\/10.1097\/AOG.0000000000003891","DOI":"10.1097\/AOG.0000000000003891"},{"key":"714_CR32","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"LA Magee","year":"2022","unstructured":"Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia, Longo DL, editor. N Engl J Med. 2022;386:1817\u201332.","journal-title":"N Engl J Med"},{"key":"714_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.preghy.2020.03.011","volume":"20","author":"S Suvakov","year":"2020","unstructured":"Suvakov S, Bonner E, Nikolic V, Jerotic D, Simic TP, Garovic VD, et al. Overlapping pathogenic signalling pathways and biomarkers in preeclampsia and cardiovascular disease. Pregnancy Hypertens. 2020;20:131\u20136.","journal-title":"Pregnancy Hypertens"},{"key":"714_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3078","author":"I Behrens","year":"2017","unstructured":"Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ. 2017. https:\/\/doi.org\/10.1136\/bmj.j3078.","journal-title":"BMJ"},{"key":"714_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCRESAHA.124.325581","volume":"136","author":"ME Countouris","year":"2025","unstructured":"Countouris ME, Bello NA. Advances in our understanding of cardiovascular diseases after preeclampsia. Circ Res. 2025;136:583\u201393. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.325581.","journal-title":"Circ Res"},{"key":"714_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000208","author":"VD Garovic","year":"2022","unstructured":"Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022. https:\/\/doi.org\/10.1161\/HYP.0000000000000208.","journal-title":"Hypertension"},{"key":"714_CR37","doi-asserted-by":"crossref","unstructured":"McNally R, Alqudah A, Obradovic D, McClements L: Elucidating the pathogenesis of pre-eclampsia using in vitro models of spiral uterine artery remodelling, Curr Hypertens Rep, 2017, 19.","DOI":"10.1007\/s11906-017-0786-2"},{"key":"714_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2024.2445556","author":"D Afrose","year":"2025","unstructured":"Afrose D, Alfonso-S\u00e1nchez S, McClements L. Targeting oxidative stress in Preeclampsia. Hypertens Pregnancy. 2025. https:\/\/doi.org\/10.1080\/10641955.2024.2445556.","journal-title":"Hypertens Pregnancy"},{"key":"714_CR39","first-page":"213","volume-title":"Epidemiology of hypertensive disorders in pregnancy: Prevalence, risk factors, predictors and prognosis","author":"M Umesawa","year":"2017","unstructured":"Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: Prevalence, risk factors, predictors and prognosis. Hypertens Res: Nature Publishing Group; 2017. p. 213\u201320."},{"key":"714_CR40","doi-asserted-by":"publisher","unstructured":"Dall\u2019Asta A, D\u2019Antonio F, Saccone G, Buca D, Mastantuoni E, Liberati M, et al.: Cardiovascular events following pregnancy complicated by pre\u2010eclampsia with emphasis on comparison between early\u2010 and late\u2010onset forms: systematic review and meta\u2010analysis, Ultrasound Obstet Gynecol 2021, 57: 698\u2013709. https:\/\/doi.org\/10.1002\/uog.22107","DOI":"10.1002\/uog.22107"},{"key":"714_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri3361","volume":"13","author":"A Erlebacher","year":"2013","unstructured":"Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol. 2013;13:23\u201333.","journal-title":"Nat Rev Immunol"},{"key":"714_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ajpath.2011.09.021","volume":"180","author":"OJ Holland","year":"2012","unstructured":"Holland OJ, Linscheid C, Hodes HC, Nauser TL, Gilliam M, Stone P, et al. Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris. Am J Pathol. 2012;180:256\u201366.","journal-title":"Am J Pathol"},{"key":"714_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01864\/full","author":"I Aneman","year":"2020","unstructured":"Aneman I, Pienaar D, Suvakov S, Simic TP, Garovic VD, McClements L. Mechanisms of key innate immune cells in early- and late-onset preeclampsia. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01864\/full.","journal-title":"Front Immunol"},{"key":"714_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13293-019-0261-7","volume":"10","author":"S Galjaard","year":"2019","unstructured":"Galjaard S, Ameye L, Lees CC, Pexsters A, Bourne T, Timmerman D, et al. Sex differences in fetal growth and immediate birth outcomes in a low-risk Caucasian population. Biol Sex Differ. 2019;10:48. https:\/\/doi.org\/10.1186\/s13293-019-0261-7.","journal-title":"Biol Sex Differ"},{"issue":"292","key":"714_CR45","first-page":"e1","volume":"211","author":"P O\u2019Tierney-Ginn","year":"2014","unstructured":"O\u2019Tierney-Ginn P, Presley L, Minium J. Hauguel deMouzon S, Catalano PM: Sex-specific effects of maternal anthropometrics on body composition at birth. Am J Obstet Gynecol. 2014;211(292):e1-292.e9.","journal-title":"Am J Obstet Gynecol"},{"key":"714_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/aji.12303","volume":"73","author":"EAL Enninga","year":"2015","unstructured":"Enninga EAL, Nevala WK, Creedon DJ, Markovic SN, Holtan SG. Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol. 2015;73:251\u201362. https:\/\/doi.org\/10.1111\/aji.12303.","journal-title":"Am J Reprod Immunol"},{"key":"714_CR47","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.3390\/jcm10133000","volume":"10","author":"AM Inkster","year":"2021","unstructured":"Inkster AM, Fern\u00e1ndez-Boyano I, Robinson WP. Sex differences are here to stay: relevance to prenatal care. J Clin Med. 2021;10:3000.","journal-title":"J Clin Med"},{"key":"714_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1550-8579(07)80004-0","volume":"4","author":"GC Di Renzo","year":"2007","unstructured":"Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome? Gend Med. 2007;4:19\u201330.","journal-title":"Gend Med"},{"key":"714_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115347","volume":"208","author":"JN Stallone","year":"2023","unstructured":"Stallone JN, Oloyo AK. Cardiovascular and metabolic actions of the androgens: testosterone a Janus-faced molecule? Biochem Pharmacol. 2023;208: 115347.","journal-title":"Biochem Pharmacol"},{"key":"714_CR50","doi-asserted-by":"publisher","unstructured":"O\u2019Shaughnessy PJ, Antignac JP, Le Bizec B, Morvan M-L, Svechnikov K, S\u00f6der O, et al.: Alternative (backdoor) androgen production and masculinization in the human fetus. Rawlins E, editor. PLOS Biol 2019, 17: e3000002. https:\/\/doi.org\/10.1371\/journal.pbio.3000002","DOI":"10.1371\/journal.pbio.3000002"},{"key":"714_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/(SICI)1096-8628(19980413)76:5<369::AID-AJMG1>3.0.CO;2-I","volume":"76","author":"LB Bazzett","year":"1998","unstructured":"Bazzett LB, Yaron Y, O\u2019Brien JE, Critchfield G, Kramer RL, Ayoub M, et al. Fetal gender impact on multiple-marker screening results. Am J Med Genet. 1998;76:369\u201371.","journal-title":"Am J Med Genet"},{"key":"714_CR52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000249159","volume":"72","author":"A Belgorosky","year":"2009","unstructured":"Belgorosky A, Guercio G, Pepe C, Saraco N, Rivarola MA. Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence. Horm Res Paediatr. 2009;72:321\u201330. https:\/\/doi.org\/10.1159\/000249159.","journal-title":"Horm Res Paediatr"},{"key":"714_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.placenta.2018.07.004","volume":"69","author":"N Berkane","year":"2018","unstructured":"Berkane N, Liere P, Lefevre G, Alfaidy N, Nahed RA, Vincent J, et al. Abnormal steroidogenesis and aromatase activity in preeclampsia. Placenta. 2018;69:40\u20139.","journal-title":"Placenta"},{"key":"714_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/1471-0528.14163","volume":"124","author":"D Jaskolka","year":"2017","unstructured":"Jaskolka D, Retnakaran R, Zinman B, Kramer C. Fetal sex and maternal risk of pre-eclampsia\/eclampsia: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2017;124:553\u201360. https:\/\/doi.org\/10.1111\/1471-0528.14163.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"714_CR55","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/dc11-1790","volume":"35","author":"PM Catalano","year":"2012","unstructured":"Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. The hyperglycemia and adverse pregnancy outcome study. Diabetes Care. 2012;35:780\u20136.","journal-title":"Diabetes Care"},{"key":"714_CR56","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2337\/dc14-2551","volume":"38","author":"R Retnakaran","year":"2015","unstructured":"Retnakaran R, Kramer CK, Ye C, Kew S, Hanley AJ, Connelly PW, et al. Fetal sex and maternal rRisk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care. 2015;38:844\u201351.","journal-title":"Diabetes Care"},{"key":"714_CR57","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/1471-0528.13519","volume":"123","author":"Z Broere-Brown","year":"2016","unstructured":"Broere-Brown Z, Schalekamp-Timmermans S, Hofman A, Jaddoe V, Steegers E. Fetal sex dependency of maternal vascular adaptation to pregnancy: a prospective population-based cohort study. BJOG An Int J Obstet Gynaecol. 2016;123:1087\u201395. https:\/\/doi.org\/10.1111\/1471-0528.13519.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"714_CR58","doi-asserted-by":"publisher","unstructured":"Decina CS, Beaumont RN, Juodakis J, Warrington NM, Patel KA, Nj\u00f8lstad PR, et al. The influence of fetal sex on maternal blood pressure in pregnancy [Internet], 2025. https:\/\/doi.org\/10.1101\/2025.01.28.25321287","DOI":"10.1101\/2025.01.28.25321287"},{"key":"714_CR59","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.placenta.2024.10.016","volume":"158","author":"N Barapatre","year":"2024","unstructured":"Barapatre N, Hansen L, Kampfer C, R\u00fcbelmann T, Schmitz C, von Koch F, et al. Trophoblast proliferation is higher in female than in male preeclamptic placentas. Placenta. 2024;158:310\u20137.","journal-title":"Placenta"},{"key":"714_CR60","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s43032-021-00466-w","volume":"28","author":"AO Karapetian","year":"2021","unstructured":"Karapetian AO, Baev OR, Sadekova AA, Krasnyi AM, Sukhikh GT. Cell-free foeta DNA as a useful marker for preeclampsia prediction. Reprod Sci. 2021;28:1563\u20139. https:\/\/doi.org\/10.1007\/s43032-021-00466-w.","journal-title":"Reprod Sci"},{"key":"714_CR61","doi-asserted-by":"publisher","unstructured":"Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: a meta-analysis. Int J Epidemiol 2016, https:\/\/doi.org\/10.1093\/ije\/dyw178","DOI":"10.1093\/ije\/dyw178"},{"key":"714_CR62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1477-7827-8-102","volume":"8","author":"LA Cole","year":"2010","unstructured":"Cole LA. Biological functions of hCG and hCG-related molecules. Repro Biol Endocrinol. 2010;8:102. https:\/\/doi.org\/10.1186\/1477-7827-8-102.","journal-title":"Repro Biol Endocrinol"},{"issue":"6","key":"714_CR63","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","volume":"66","author":"A Kautzky-Willer","year":"2023","unstructured":"Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66(6):986\u20131002. https:\/\/doi.org\/10.1007\/s00125-023-05891-x.","journal-title":"Diabetologia"},{"issue":"1","key":"714_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","volume":"17","author":"GH Goossens","year":"2021","unstructured":"Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47\u201366. https:\/\/doi.org\/10.1038\/s41574-020-00431-8.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"714_CR65","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","volume":"37","author":"A Kautzky-Willer","year":"2016","unstructured":"Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278\u2013316. https:\/\/doi.org\/10.1210\/er.2015-1137.","journal-title":"Endocr Rev"},{"issue":"11","key":"714_CR66","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1172\/JCI140223","volume":"130","author":"JC Link","year":"2020","unstructured":"Link JC, Wiese CB, Chen X, Avetisyan R, Ronquillo E, Ma F, et al. X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity. J Clin Invest. 2020;130(11):5688\u2013702. https:\/\/doi.org\/10.1172\/JCI140223.","journal-title":"J Clin Invest"},{"issue":"12","key":"714_CR67","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/jama.2018.0423","volume":"319","author":"R Rubin","year":"2018","unstructured":"Rubin R. Postmenopausal women with a \u201cnormal\u201d BMI might be overweight or even obese. JAMA. 2018;319(12):1185\u20137. https:\/\/doi.org\/10.1001\/jama.2018.0423.","journal-title":"JAMA"},{"key":"714_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156052","volume":"161","author":"R Conforto","year":"2024","unstructured":"Conforto R, Rizzo V, Russo R, Mazza E, Maurotti S, Pujia C, et al. Advances in body composition and gender differences in susceptibility to frailty syndrome: Role of osteosarcopenic obesity. Metabolism. 2024;161: 156052. https:\/\/doi.org\/10.1016\/j.metabol.2024.156052.","journal-title":"Metabolism"},{"key":"714_CR69","doi-asserted-by":"publisher","unstructured":"Mauvais-Jarvis F: Sex differences in energy metabolism: natural selection, mechanisms and consequences. Nat Rev Nephrol, 2024,c20(1): 56\u201369. https:\/\/doi.org\/10.1038\/s41581-023-00781-2.","DOI":"10.1038\/s41581-023-00781-2"},{"issue":"12","key":"714_CR70","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1073\/pnas.1215626110","volume":"110","author":"S Thurner","year":"2013","unstructured":"Thurner S, Klimek P, Szell M, Duftschmid G, Endel G, Kautzky-Willer A, et al. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century. Proc Natl Acad Sci U S A. 2013;110(12):4703\u20137. https:\/\/doi.org\/10.1073\/pnas.1215626110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"714_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.971048","volume":"13","author":"H Brettle","year":"2022","unstructured":"Brettle H, Tran V, Drummond GR, Franks AE, Petrovski S, Vinh A, et al. Sex hormones, intestinal inflammation, and the gut microbiome: Major influencers of the sexual dimorphisms in obesity. Front Immunol. 2022;13: 971048. https:\/\/doi.org\/10.3389\/fimmu.2022.971048.","journal-title":"Front Immunol"},{"issue":"7533","key":"714_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","volume":"332","author":"R Huxley","year":"2006","unstructured":"Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73\u20138. https:\/\/doi.org\/10.1136\/bmj.38678.389583.7C.","journal-title":"BMJ"},{"key":"714_CR73","doi-asserted-by":"publisher","unstructured":"Prospective Studies Collaboration, Asia Pacific Cohort Studies Collaboration. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol, 2018, 6(7): 538\u2013546. https:\/\/doi.org\/10.1016\/S2213-8587(18)30079-2.","DOI":"10.1016\/S2213-8587(18)30079-2"},{"issue":"24","key":"714_CR74","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1161\/CIRCULATIONAHA.118.039100","volume":"139","author":"AK Wright","year":"2019","unstructured":"Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, et al. Cardiovascular risk and risk fFactor management in type 2 diabetes mellitus. Circulation. 2019;139(24):2742\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.039100.","journal-title":"Circulation"},{"issue":"2","key":"714_CR75","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc20-1137","volume":"44","author":"TM Peters","year":"2021","unstructured":"Peters TM, Holmes MV, Richards JB, Palmer T, Forgetta V, Lindgren CM, et al. Sex differences in the risk of coronary heart disease associated with type 2 diabetes A Mendelian randomization analysis. Diabetes Care. 2021;44(2):556\u201362. https:\/\/doi.org\/10.2337\/dc20-1137.","journal-title":"Diabetes Care"},{"issue":"11","key":"714_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11892-020-01348-2","volume":"20","author":"J Harreiter","year":"2020","unstructured":"Harreiter J, Fadl H, Kautzky-Willer A, Simmons D. Do Women with diabetes need more intensive action for cardiovascular reduction than men with diabetes? Curr Diab Rep. 2020;20(11):61. https:\/\/doi.org\/10.1007\/s11892-020-01348-2.","journal-title":"Curr Diab Rep"},{"issue":"5","key":"714_CR77","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2337\/dc19-2257","volume":"43","author":"KK Clemens","year":"2020","unstructured":"Clemens KK, Woodward M, Neal B, Zinman B. Sex disparities in cardiovascular outcome trials of populations with diabetes: a systematic review and meta-analysis. Diabetes Care. 2020;43(5):1157\u201363. https:\/\/doi.org\/10.2337\/dc19-2257.","journal-title":"Diabetes Care"},{"issue":"17","key":"714_CR78","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.jacc.2024.08.022","volume":"84","author":"S Verma","year":"2024","unstructured":"Verma S, Colhoun HM, Dicker D, Hovingh GK, Kahn SE, Kautzky-Willer A, et al. Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT): outcomes by sex. J Am Coll Cardiol. 2024;84(17):1678\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.022.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"714_CR79","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1089\/jwh.2023.0059","volume":"32","author":"A Hammer","year":"2023","unstructured":"Hammer A, Hofer F, Kazem N, Koller L, Steinacher E, Baumer U, et al. Sex-related disparities in prescription patterns of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and heart failure. J Womens Health (Larchmt). 2023;32(11):1219\u201328. https:\/\/doi.org\/10.1089\/jwh.2023.0059.","journal-title":"J Womens Health (Larchmt)"},{"issue":"9","key":"714_CR80","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s00125-019-4926-x","volume":"62","author":"T Ohkuma","year":"2019","unstructured":"Ohkuma T, Komorita Y, Peters SAE, Woodward M. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia. 2019;62(9):1550\u201360. https:\/\/doi.org\/10.1007\/s00125-019-4926-x.","journal-title":"Diabetologia"},{"issue":"12","key":"714_CR81","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.2337\/dc23-1135","volume":"46","author":"MT Ma\u0142ecki","year":"2023","unstructured":"Ma\u0142ecki MT, Batterham RL, Sattar N, Levine JA, Rodr\u00edguez A, Bergman BK, et al. Predictors of >\/=15% weight reduction and associated changes in cardiometabolic risk factors with tirzepatide in adults with type 2 diabetes in SURPASS 1\u20134. Diabetes Care. 2023;46(12):2292\u20139. https:\/\/doi.org\/10.2337\/dc23-1135.","journal-title":"Diabetes Care"},{"issue":"3","key":"714_CR82","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/01.RES.67.3.753","volume":"67","author":"MK Chung","year":"1990","unstructured":"Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res. 1990;67(3):753\u201363.","journal-title":"Circ Res"},{"issue":"5068","key":"714_CR83","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1631560","volume":"257","author":"MS Finkel","year":"1992","unstructured":"Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257(5068):387\u20139.","journal-title":"Science"},{"issue":"1","key":"714_CR84","first-page":"H250","volume":"275","author":"P Yue","year":"1998","unstructured":"Yue P, Massie BM, Simpson PC, Long CS. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol. 1998;275(1):H250\u20138.","journal-title":"Am J Physiol"},{"issue":"12","key":"714_CR85","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1161\/01.CIR.97.12.1136","volume":"97","author":"P Aukrust","year":"1998","unstructured":"Aukrust P, Ueland T, Muller F, Andreassen AK, Nordoy I, Aas H, et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 1998;97(12):1136\u201343.","journal-title":"Circulation"},{"issue":"4","key":"714_CR86","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"323","author":"B Levine","year":"1990","unstructured":"Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323(4):236\u201341.","journal-title":"N Engl J Med"},{"issue":"11","key":"714_CR87","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","volume":"107","author":"RS Vasan","year":"2003","unstructured":"Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003;107(11):1486\u201391.","journal-title":"Circulation"},{"issue":"1","key":"714_CR88","first-page":"101","volume":"152","author":"PE Kolattukudy","year":"1998","unstructured":"Kolattukudy PE, Quach T, Bergese S, Breckenridge S, Hensley J, Altschuld R, et al. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol. 1998;152(1):101\u201311.","journal-title":"Am J Pathol"},{"issue":"6","key":"714_CR89","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1172\/JCI58109","volume":"121","author":"H Tilg","year":"2011","unstructured":"Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011;121(6):2126\u201332.","journal-title":"J Clin Invest"},{"issue":"1","key":"714_CR90","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1152\/physrev.00029.2021","volume":"102","author":"G Kararigas","year":"2022","unstructured":"Kararigas G. Sex-biased mechanisms of cardiovascular complications in COVID-19. Physiol Rev. 2022;102(1):333\u20137.","journal-title":"Physiol Rev"},{"issue":"11","key":"714_CR91","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.mayocp.2020.09.017","volume":"95","author":"O Ritter","year":"2020","unstructured":"Ritter O, Kararigas G. Sex-Biased vulnerability of the heart to COVID-19. Mayo Clin Proc. 2020;95(11):2332\u20135.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"714_CR92","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jacc.2019.06.077","volume":"74","author":"ES Lau","year":"2019","unstructured":"Lau ES, Paniagua SM, Guseh JS, Bhambhani V, Zanni MV, Courchesne P, et al. Sex differences in circulating biomarkers of cardiovascular disease. J Am Coll Cardiol. 2019;74(12):1543\u201353.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"714_CR93","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.mayocp.2019.11.026","volume":"95","author":"L Gaignebet","year":"2020","unstructured":"Gaignebet L, Kandula MM, Lehmann D, Knosalla C, Kreil DP, Kararigas G. Sex- specific human cardiomyocyte gene regulation in left ventricular pPressure overload. Mayo Clin Proc. 2020;95(4):688\u201397.","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"714_CR94","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/ejhf.171","volume":"16","author":"G Kararigas","year":"2014","unstructured":"Kararigas G, Dworatzek E, Petrov G, Summer H, Schulze TM, Baczko I, et al. Sex- dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload. Eur J Heart Fail. 2014;16(11):1160\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"714_CR95","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1021\/pr500749j","volume":"13","author":"G Kararigas","year":"2014","unstructured":"Kararigas G, Fliegner D, Forler S, Klein O, Schubert C, Gustafsson JA, et al. Comparative proteomic analysis reveals sex and estrogen receptor beta effects in the pressure overloaded heart. J Proteome Res. 2014;13(12):5829\u201336.","journal-title":"J Proteome Res"},{"issue":"8","key":"714_CR96","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1152\/physiolgenomics.00199.2010","volume":"43","author":"G Kararigas","year":"2011","unstructured":"Kararigas G, Fliegner D, Gustafsson JA. Regitz-Zagrosek Vz: Role of the estrogen\/estrogen-receptor-beta axis in the genomic response to pressure overload- induced hypertrophy. Physiol Genomics. 2011;43(8):438\u201346.","journal-title":"Physiol Genomics"},{"issue":"6","key":"714_CR97","doi-asserted-by":"publisher","first-page":"R1597","DOI":"10.1152\/ajpregu.00825.2009","volume":"298","author":"D Fliegner","year":"2010","unstructured":"Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, et al. Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol, Regul Integr Comp Physiol. 2010;298(6):R1597\u2013606.","journal-title":"Am J Physiol, Regul Integr Comp Physiol"},{"issue":"1","key":"714_CR98","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13293-020-00306-7","volume":"11","author":"AR Sabbatini","year":"2020","unstructured":"Sabbatini AR, Kararigas G. Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biol Sex Differ. 2020;11(1):31.","journal-title":"Biol Sex Differ"},{"issue":"9","key":"714_CR99","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jacc.2019.12.049","volume":"75","author":"AR Sabbatini","year":"2020","unstructured":"Sabbatini AR, Kararigas G. Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol. 2020;75(9):1074\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"714_CR100","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1210\/edrv.23.1.0456","volume":"23","author":"J Pfeilschifter","year":"2002","unstructured":"Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23(1):90\u2013119.","journal-title":"Endocr Rev"},{"issue":"1","key":"714_CR101","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0015-0282(01)02934-X","volume":"77","author":"CK Sites","year":"2002","unstructured":"Sites CK, Toth MJ, Cushman M, L\u2019Hommedieu GD, Tchernof A, Tracy RP, et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steri. 2002;77(1):128\u201335.","journal-title":"Fertil Steri"},{"issue":"3","key":"714_CR102","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","volume":"100","author":"HL Ji","year":"2020","unstructured":"Ji HL, Zhao R, Matalon S, Matthay MA. Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev. 2020;100(3):1065\u201375.","journal-title":"Physiol Rev"},{"issue":"1","key":"714_CR103","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nm1525","volume":"13","author":"Q Gao","year":"2007","unstructured":"Gao Q, Mezei G, Nie Y, Rao Y, Choi CS, Bechmann I, et al. Anorectic estrogen mimics leptin\u2019s effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med. 2007;13(1):89\u201394.","journal-title":"Nat Med"},{"issue":"2","key":"714_CR104","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1152\/ajpendo.00504.2009","volume":"298","author":"V Ribas","year":"2010","unstructured":"Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol, Endocrinol Metab. 2010;298(2):E304\u201319.","journal-title":"Am J Physiol, Endocrinol Metab"},{"issue":"2","key":"714_CR105","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cyto.2015.01.007","volume":"72","author":"KY Shivers","year":"2015","unstructured":"Shivers KY, Amador N, Abrams L, Hunter D, Jenab S, Quinones-Jenab V. Estrogen alters baseline and inflammatory-induced cytokine levels independent from hypothalamic-pituitary-adrenal axis activity. Cytokine. 2015;72(2):121\u20139.","journal-title":"Cytokine"},{"issue":"5","key":"714_CR106","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1933719108317583","volume":"15","author":"O Guzeloglu-Kayisli","year":"2008","unstructured":"Guzeloglu-Kayisli O, Halis G, Taskiran S, Kayisli UA, Arici A. DNA-binding ability of NF-kappaB is affected differently by ERalpha and ERbeta and its activation results in inhibition of estrogen responsiveness. Reprod Sci. 2008;15(5):493\u2013505.","journal-title":"Reprod Sci"},{"issue":"1","key":"714_CR107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13293-017-0151-9","volume":"8","author":"RS Santos","year":"2017","unstructured":"Santos RS, de Fatima LA, Frank AP, Carneiro EM, Clegg DJ. The effects of 17 alpha-estradiol to inhibit inflammation in vitro. Biol Sex Differ. 2017;8(1):30.","journal-title":"Biol Sex Differ"},{"key":"714_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2023.100654","volume":"33","author":"A Angelov","year":"2023","unstructured":"Angelov A, Connelly PJ, Delles C, Kararigas G. Sex-biased and sex hormone- dependent regulation of apolipoprotein A1. Curr Opin Physio. 2023;33: 100654.","journal-title":"Curr Opin Physio"},{"issue":"1","key":"714_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1210\/jc.2007-1738","volume":"93","author":"R Karim","year":"2008","unstructured":"Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab. 2008;93(1):131\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"714_CR110","doi-asserted-by":"publisher","unstructured":"Collaboration GBDCKD: Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2020, 10225:709\u2013733; https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3.","DOI":"10.1016\/S0140-6736(20)30045-3"},{"issue":"20","key":"714_CR111","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"issue":"13","key":"714_CR112","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305. https:\/\/doi.org\/10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"issue":"20","key":"714_CR113","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"issue":"5","key":"714_CR114","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1681\/ASN.0000000000000089","volume":"34","author":"L Chen","year":"2023","unstructured":"Chen L, Chou CL, Yang CR, Knepper MA. Multiomics analyses reveal sex differences in mouse renal proximal subsegments. J Am Soc Nephrol. 2023;34(5):829\u201345. https:\/\/doi.org\/10.1681\/ASN.0000000000000089.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"714_CR115","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12882-020-01946-y","volume":"21","author":"SA Kalucki","year":"2020","unstructured":"Kalucki SA, Lardi C, Garessus J, Kfoury A, Grabherr S, Burnier M, et al. Reference values and sex differences in absolute and relative kidney size. A Swiss autopsy study. BMC Nephrol. 2020;21(1):289. https:\/\/doi.org\/10.1186\/s12882-020-01946-y.","journal-title":"BMC Nephrol"},{"issue":"2","key":"714_CR116","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/path.1711710212","volume":"171","author":"L Moore","year":"1993","unstructured":"Moore L, Williams R, Staples A. Glomerular dimensions in children under 16 years of age. J Pathol. 1993;171(2):145\u201350. https:\/\/doi.org\/10.1002\/path.1711710212.","journal-title":"J Pathol"},{"issue":"9 Pt 1","key":"714_CR117","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/s0895-7061(01)02164-1","volume":"14","author":"AA Khraibi","year":"2001","unstructured":"Khraibi AA, Liang M, Berndt TJ. Role of gender on renal interstitial hydrostatic pressure and sodium excretion in rats. Am J Hypertens. 2001;14(9 Pt 1):893\u20136. https:\/\/doi.org\/10.1016\/s0895-7061(01)02164-1.","journal-title":"Am J Hypertens"},{"issue":"8","key":"714_CR118","doi-asserted-by":"publisher","first-page":"F901","DOI":"10.1152\/ajprenal.00288.2014","volume":"307","author":"KM Mirabito","year":"2014","unstructured":"Mirabito KM, Hilliard LM, Kett MM, Brown RD, Booth SC, Widdop RE, et al. Sex- and age- related differences in the chronic pressure-natriuresis relationship: role of the angiotensin type 2 receptor. Am J Physiol, Renal Physiol. 2014;307(8):F901-907. https:\/\/doi.org\/10.1152\/ajprenal.00288.2014.","journal-title":"Am J Physiol, Renal Physiol"},{"issue":"1","key":"714_CR119","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41581-023-00757-2","volume":"20","author":"AA McDonough","year":"2024","unstructured":"McDonough AA, Harris AN, Xiong LI, Layton AT. Sex differences in renal transporters: assessment and functional consequences. Nat Rev Nephrol. 2024;20(1):21\u201336. https:\/\/doi.org\/10.1038\/s41581-023-00757-2.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"714_CR120","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1681\/ASN.2017030295","volume":"28","author":"LC Veiras","year":"2017","unstructured":"Veiras LC, Girardi ACC, Curry J, Pei L, Ralph DL, Tran A, et al. Sexual dimorphic pattern of renal transporters and electrolyte homeostasis. J Am Soc Nephrol. 2017;28(12):3504\u201317. https:\/\/doi.org\/10.1681\/ASN.2017030295.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"714_CR121","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1046\/j.1523-1755.1999.00647.x","volume":"56","author":"SE Mulroney","year":"1999","unstructured":"Mulroney SE, Woda C, Johnson M, Pesce C. Gender differences in renal growth and function after uninephrectomy in adult rats. Kidney Int. 1999;56(3):944\u201353. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00647.x.","journal-title":"Kidney Int"},{"issue":"4","key":"714_CR122","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ki.1996.425","volume":"50","author":"G Kwan","year":"1996","unstructured":"Kwan G, Neugarten J, Sherman M, Ding Q, Fotadar U, Lei J, et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int. 1996;50(4):1173\u20139. https:\/\/doi.org\/10.1038\/ki.1996.425.","journal-title":"Kidney Int"},{"issue":"3","key":"714_CR123","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/nep.13806","volume":"26","author":"I Lima-Posada","year":"2021","unstructured":"Lima-Posada I, Bobadilla NA. Understanding the opposite effects of sex hormones in mediating renal injury. Nephrology (Carlton). 2021;26(3):217\u201326. https:\/\/doi.org\/10.1111\/nep.13806.","journal-title":"Nephrology (Carlton)"},{"key":"714_CR124","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0022-5347(17)71560-1","volume":"42","author":"H Selye","year":"1939","unstructured":"Selye H. The effect of testosterone on the kidney. J Urol. 1939;42:4.","journal-title":"J Urol"},{"issue":"1","key":"714_CR125","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41581-023-00784-z","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye NC, Carrero JJ, Hecking M, Jager KJ. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat Rev Nephrol. 2024;20(1):7\u201320. https:\/\/doi.org\/10.1038\/s41581-023-00784-z.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"714_CR126","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1681\/ASN.V112319","volume":"11","author":"J Neugarten","year":"2000","unstructured":"Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11(2):319\u201329. https:\/\/doi.org\/10.1681\/ASN.V112319.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"714_CR127","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/ndt\/gfg317","volume":"18","author":"TH Jafar","year":"2003","unstructured":"Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, et al. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant. 2003;18(10):2047\u201353. https:\/\/doi.org\/10.1093\/ndt\/gfg317.","journal-title":"Nephrol Dial Transplant"},{"key":"714_CR128","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f324","volume":"346","author":"D Nitsch","year":"2013","unstructured":"Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta analysis. BMJ. 2013;346: f324. https:\/\/doi.org\/10.1136\/bmj.f324.","journal-title":"BMJ"},{"issue":"1","key":"714_CR129","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/ATVBAHA.124.321629","volume":"45","author":"H Ji","year":"2025","unstructured":"Ji H, Sabanayagam C, Matsushita K, Cheng CY, Rim TH, Sheng B, et al. Sex differences in cardiovascular-kidney-metabolic sSyndrome: 30-year US trends and mortality risks-brief report. Arterioscler Thromb Vasc Biol. 2025;45(1):157\u201361. https:\/\/doi.org\/10.1161\/ATVBAHA.124.321629.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"714_CR130","doi-asserted-by":"crossref","unstructured":"Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, et al.: Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int, 2002","DOI":"10.1046\/j.1523-1755.2002.00156.x"},{"issue":"2","key":"714_CR131","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.ajkd.2018.07.019","volume":"73","author":"P Ahearn","year":"2019","unstructured":"Ahearn P, Johansen KL, McCulloch CE, Grimes BA, Ku E. Sex disparities in risk of mortality among children with ESRD. Am J Kidney Dis. 2019;73(2):156\u201362. https:\/\/doi.org\/10.1053\/j.ajkd.2018.07.019.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"714_CR132","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ki.2014.342","volume":"87","author":"BL Laskin","year":"2015","unstructured":"Laskin BL, Mitsnefes MM, Dahhou M, Zhang X, Foster BJ. The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States. Kidney Int. 2015;87(3):575\u201383. https:\/\/doi.org\/10.1038\/ki.2014.342.","journal-title":"Kidney Int"},{"issue":"3","key":"714_CR133","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.kint.2021.11.032","volume":"101","author":"RI Sugianto","year":"2022","unstructured":"Sugianto RI, Memaran N, Schmidt BMW, Doyon A, Thurn-Valsassina D, Alpay H, et al. Findings from 4C-T study demonstrate an increased cardiovascular burden in girls with end stage kidney disease and kidney transplantation. Kidney Int. 2022;101(3):585\u201396. https:\/\/doi.org\/10.1016\/j.kint.2021.11.032.","journal-title":"Kidney Int"},{"key":"714_CR134","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ-2021-068247","volume":"375","author":"NL De La Mata","year":"2021","unstructured":"De La Mata NL, Rosales B, MacLeod G, Kelly PJ, Masson P, Morton RL, et al. Sex differences in mortality among binational cohort of people with chronic kidney disease population based data linkage study. BMJ. 2021;375: e068247. https:\/\/doi.org\/10.1136\/BMJ-2021-068247.","journal-title":"BMJ"},{"issue":"3","key":"714_CR135","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.ajkd.2013.09.011","volume":"63","author":"C van Walraven","year":"2014","unstructured":"van Walraven C, Manuel DG, Knoll G. Survival trends in ESRD patients compared with the general population in the United States. Am J Kidney Dis. 2014;63(3):491\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2013.09.011.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"714_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254554","volume":"16","author":"S Shajahan","year":"2021","unstructured":"Shajahan S, Amin J, Phillips JK, Hildreth CM. Relationship between sex and cardiovascular mortality in chronic kidney disease: a systematic review and meta-analysis. PLoS ONE. 2021;16(7): e0254554. https:\/\/doi.org\/10.1371\/journal.pone.0254554.","journal-title":"PLoS ONE"},{"issue":"2","key":"714_CR137","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1053\/j.ajkd.2021.01.020","volume":"78","author":"SM Toth-Manikowski","year":"2021","unstructured":"Toth-Manikowski SM, Yang W, Appel L, Chen J, Deo R, Frydrych A, et al. Sex differences in cardiovascular outcomes in CKD: findings from the CRIC study. Am J Kidney Dis. 2021;78(2):200-209.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.020.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"714_CR138","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1053\/j.ajkd.2020.11.026","volume":"78","author":"O Swartling","year":"2021","unstructured":"Swartling O, Rydell H, Stendahl M, Segelmark M, Trolle Lagerros Y, Evans M. CKD progression and mortality among men and women: a nationwide study in sweden. Am J Kidney Dis. 2021;78(2):190-199.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2020.11.026.","journal-title":"Am J Kidney Dis"},{"key":"714_CR139","doi-asserted-by":"publisher","first-page":"e0221044","DOI":"10.1371\/journal.pone.0221044","volume":"14","author":"CJ Currie","year":"2019","unstructured":"Currie CJ, Berni ER, Berni TR, Jenkins-Jones S, Sinsakul M, Jermutus L, et al. Major adverse cardiovascular events in people with chronic kidney disease in relation to diseas severity and diabetes status. PLoS ONE. 2019;14:e0221044. https:\/\/doi.org\/10.1371\/journal.pone.0221044.","journal-title":"PLoS ONE"},{"issue":"7","key":"714_CR140","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s00392-021-01872-5","volume":"110","author":"CY Jung","year":"2021","unstructured":"Jung CY, Heo GY, Park JT, Joo YS, Kim HW, Lim H, et al. Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD. Clin Res Cardiol. 2021;110(7):1116\u201327. https:\/\/doi.org\/10.1007\/s00392-021-01872-5.","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"714_CR141","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1053\/j.ajkd.2024.04.013","volume":"84","author":"AL Faucon","year":"2024","unstructured":"Faucon AL, Lambert O, Massy Z, Drueke TB, Combe C, Fouque D, et al. Sex and the risk of atheromatous and nonatheromatous cardiovascular disease in CKD: findings from the CKD-REIN cohort study. Am J Kidney Dis. 2024;84(5):546-556.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2024.04.013.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"714_CR142","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.atherosclerosis.2008.08.002","volume":"203","author":"LH Oterdoom","year":"2009","unstructured":"Oterdoom LH, de Vries AP, Gansevoort RT, de Jong PE, Gans RO, Bakker SJ. Fasting insulin is a stronger cardiovascular risk factor in women than in men. Atherosclerosis. 2009;203(2):640\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.08.002.","journal-title":"Atherosclerosis"},{"issue":"3","key":"714_CR143","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2337\/dc13-1755","volume":"37","author":"RR Kalyani","year":"2014","unstructured":"Kalyani RR, Lazo M, Ouyang P, Turkbey E, Chevalier K, Brancati F, et al. Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care. 2014;37(3):830\u20138. https:\/\/doi.org\/10.2337\/dc13-1755.","journal-title":"Diabetes Care"},{"issue":"10","key":"714_CR144","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00125-019-4939-5","volume":"62","author":"AG Huebschmann","year":"2019","unstructured":"Huebschmann AG, Huxley RR, Kohrt WM, Zeitler P, Regensteiner JG, Reusch JEB. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62(10):1761\u201372. https:\/\/doi.org\/10.1007\/s00125-019-4939-5.","journal-title":"Diabetologia"},{"issue":"6","key":"714_CR145","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2337\/dc06-0062","volume":"29","author":"CC Cowie","year":"2006","unstructured":"Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999\u20132002. Diabetes Care. 2006;29(6):1263\u20138. https:\/\/doi.org\/10.2337\/dc06-0062.","journal-title":"Diabetes Care"},{"issue":"12","key":"714_CR146","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/ndt\/gfad118","volume":"38","author":"PI Georgianos","year":"2023","unstructured":"Georgianos PI, Agarwal R. Hypertension in chronic kidney disease-treatment standard 2023. Nephrol Dial Transplant. 2023;38(12):2694\u2013703. https:\/\/doi.org\/10.1093\/ndt\/gfad118.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"714_CR147","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamacardio.2019.5306","volume":"5","author":"H Ji","year":"2020","unstructured":"Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Bairey Merz CN, et al. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol. 2020;5(3):19\u201326. https:\/\/doi.org\/10.1001\/jamacardio.2019.5306.","journal-title":"JAMA Cardiol"},{"issue":"7","key":"714_CR148","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/CIRCULATIONAHA.120.049360","volume":"143","author":"H Ji","year":"2021","unstructured":"Ji H, Niiranen TJ, Rader F, Henglin M, Kim A, Ebinger JE, et al. Sex differences in blood pressure associations with cardiovascular outcomes. Circulation. 2021;143(7):761\u20133. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049360.","journal-title":"Circulation"},{"key":"714_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01135-0","author":"SK Masenga","year":"2025","unstructured":"Masenga SK, Wandira N, Cattivelli-Murdoch G, Saleem M, Beasley H, Hinton A Jr, et al. Salt sensitivity of blood pressure: mechanisms and sex-specific differences. Nat Rev Cardiol. 2025. https:\/\/doi.org\/10.1038\/s41569-025-01135-0.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"714_CR150","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/ATVBAHA.124.322169","volume":"45","author":"AC Kwan","year":"2025","unstructured":"Kwan AC, Wang M, Ji H, Claggett B, Ouyang D, Trivedi HD, et al. Sex-divergent blood pressure associations with multiorgan system metabolic stress-brief report. Arterioscler Thromb Vasc Biol. 2025;45(4):557\u201361. https:\/\/doi.org\/10.1161\/ATVBAHA.124.322169.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"714_CR151","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.clnu.2024.03.005","volume":"43","author":"YJ Liu","year":"2024","unstructured":"Liu YJ, Li FR, Han WW, Liu Y, Liu Y, Wang JM, et al. Relationship of microvascular complications and healthy lifestyle with all-cause and cardiovascular mortality in women compared with men with type 2 diabetes. Clin Nutr. 2024;43(4):1033\u201340. https:\/\/doi.org\/10.1016\/j.clnu.2024.03.005.","journal-title":"Clin Nutr"},{"issue":"4","key":"714_CR152","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/HJH.0000000000001619","volume":"36","author":"CG Foy","year":"2018","unstructured":"Foy CG, Lovato LC, Vitolins MZ, Bates JT, Campbell R, Cushman WC, et al. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial. J Hypertens. 2018;36(4):904\u201315. https:\/\/doi.org\/10.1097\/HJH.0000000000001619.","journal-title":"J Hypertens"},{"issue":"10","key":"714_CR153","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1681\/ASN.2022030373","volume":"33","author":"O Swartling","year":"2022","unstructured":"Swartling O, Yang Y, Clase CM, Fu EL, Hecking M, Hodlmoser S, et al. Sex differences in the recognition, monitoring, and management of CKD in health care: an observational cohort study. J Am Soc Nephrol. 2022;33(10):1903\u201314. https:\/\/doi.org\/10.1681\/ASN.2022030373.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"714_CR154","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/CIRCULATIONAHA.117.028595","volume":"137","author":"A O'Neil","year":"2018","unstructured":"O\u2019Neil A, Scovelle AJ, Milner AJ, Kavanagh A. gender\/sex as a social determinant of cardiovascular risk. Circulation. 2018;137(8):854\u201364. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028595.","journal-title":"Circulation"},{"issue":"1","key":"714_CR155","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2337\/dc07-1244","volume":"31","author":"A Ferrara","year":"2008","unstructured":"Ferrara A, Mangione CM, Kim C, Marrero DG, Curb D, Stevens M, et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients wit diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care. 2008;31(1):69\u201374. https:\/\/doi.org\/10.2337\/dc07-1244.","journal-title":"Diabetes Care"},{"key":"714_CR156","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/957105","volume":"2015","author":"G Russo","year":"2015","unstructured":"Russo G, Pintaudi B, Giorda C, Lucisano G, Nicolucci A, Cristofaro MR, et al. Age- and gender-related differences in LDL-cholesterol management in outpatients with type 2 diabetes mellitus. Int J Endocrinol. 2015;2015: 957105. https:\/\/doi.org\/10.1155\/2015\/957105.","journal-title":"Int J Endocrinol"},{"issue":"40","key":"714_CR157","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/eurheartj\/ehv161","volume":"36","author":"GM Rosano","year":"2015","unstructured":"Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, et al. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. Eur Heart J. 2015;36(40):2677\u201380. https:\/\/doi.org\/10.1093\/eurheartj\/ehv161.","journal-title":"Eur Heart J"},{"issue":"8","key":"714_CR158","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2215\/CJN.05150418","volume":"13","author":"DM Roberts","year":"2018","unstructured":"Roberts DM, Sevastos J, Carland JE, Stocker SL, Lea-Henry TN. Clinical pharmacokinetics in kidney disease: application to rational design of dosing regimens. Clin J Am Soc Nephrol. 2018;13(8):1254\u201363. https:\/\/doi.org\/10.2215\/CJN.05150418.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"714_CR159","doi-asserted-by":"publisher","first-page":"537","DOI":"10.34172\/apb.2024.056","volume":"14","author":"T Faghihi","year":"2024","unstructured":"Faghihi T, Assadi F. Sex differences on the pharmacokinetics of drugs for children with chronic kidney disease: A narrative review. Adv Pharm Bull. 2024;14(3):537\u201342. https:\/\/doi.org\/10.34172\/apb.2024.056.","journal-title":"Adv Pharm Bull"},{"issue":"9","key":"714_CR160","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1681\/ASN.2005101095","volume":"17","author":"JA Miller","year":"2006","unstructured":"Miller JA, Cherney DZ, Duncan JA, Lai V, Burns KD, Kennedy CR, et al. Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol. 2006;17(9):2554\u201360. https:\/\/doi.org\/10.1681\/ASN.2005101095.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"714_CR161","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/oby.20608","volume":"22","author":"AA Zalucky","year":"2014","unstructured":"Zalucky AA, Nicholl DD, Mann MC, Hemmelgarn BR, Turin TC, Macrae JM, et al. Sex influences the effect of body mass index on the vascular response to angiotensin II in humans. Obesity (Silver Spring). 2014;22(3):739\u201346. https:\/\/doi.org\/10.1002\/oby.20608.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"714_CR162","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1046\/j.1523-1755.1999.00260.x","volume":"55","author":"JA Miller","year":"1999","unstructured":"Miller JA, Anacta LA, Cattran DC. Impact of gender on the renal response to angiotensin II. Kidney Int. 1999;55(1):278\u201385. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00260.x.","journal-title":"Kidney Int"},{"issue":"2","key":"714_CR163","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1476-5381.2012.01922.x","volume":"168","author":"W Kittikulsuth","year":"2013","unstructured":"Kittikulsuth W, Sullivan JC, Pollock DM. ET-1 actions in the kidney: evidence for sex differences. Br J Pharmacol. 2013;168(2):318\u201326. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01922.x.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"714_CR164","doi-asserted-by":"publisher","first-page":"H1569","DOI":"10.1152\/ajpheart.00396.2018","volume":"315","author":"AE Stanhewicz","year":"2018","unstructured":"Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol, Heart Circ Physiol. 2018;315(6):H1569\u201388. https:\/\/doi.org\/10.1152\/ajpheart.00396.2018.","journal-title":"Am J Physiol, Heart Circ Physiol"},{"issue":"3","key":"714_CR165","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00125-024-06326-x","volume":"68","author":"JD Smeijer","year":"2025","unstructured":"Smeijer JD, de Vries ST, Kohan DE, Hou FF, Heerspink HJL. Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial. Diabetologia. 2025;68(3):516\u201325. https:\/\/doi.org\/10.1007\/s00125-024-06326-x.","journal-title":"Diabetologia"},{"issue":"3","key":"714_CR166","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00125-024-06325-y","volume":"68","author":"ST de Vries","year":"2025","unstructured":"de Vries ST, Pena MJ, Tye SC, Peters SAE, van Raalte DH, Arnott C, et al. Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials. Diabetologia. 2025;68(3):507\u201315. https:\/\/doi.org\/10.1007\/s00125-024-06325-y.","journal-title":"Diabetologia"},{"issue":"2","key":"714_CR167","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.semnephrol.2022.04.005","volume":"42","author":"SM Dumanski","year":"2022","unstructured":"Dumanski SM, Eckersten D, Piccoli GB. Reproductive health in chronic kidney disease: the implications of sex and gender. Semin Nephrol. 2022;42(2):142\u201352. https:\/\/doi.org\/10.1016\/j.semnephrol.2022.04.005.","journal-title":"Semin Nephrol"},{"issue":"11","key":"714_CR168","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/ndt\/gfw084","volume":"31","author":"SB Ahmed","year":"2016","unstructured":"Ahmed SB, Ramesh S. Sex hormones in women with kidney disease. Nephrol Dial Transplant. 2016;31(11):1787\u201395. https:\/\/doi.org\/10.1093\/ndt\/gfw084.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"714_CR169","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5301\/JN.2011.8481","volume":"25","author":"P Iglesias","year":"2012","unstructured":"Iglesias P, Carrero JJ, Diez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol. 2012;25(1):31\u201342. https:\/\/doi.org\/10.5301\/JN.2011.8481.","journal-title":"J Nephrol"},{"key":"714_CR170","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1530\/EC-22-0061","volume":"11","author":"AC van der Burgh","year":"2022","unstructured":"van der Burgh AC, Khan SR, Neggers S, Hoorn EJ, Chaker L. The role of serum testosterone and dehydroepiandrosterone sulfate in kidney function and clinical outcomes in chronic kidne disease: a systematic review and meta-analysis. Endocr Connect. 2022;11:6. https:\/\/doi.org\/10.1530\/EC-22-0061.","journal-title":"Endocr Connect"},{"key":"714_CR171","doi-asserted-by":"publisher","first-page":"e15490","DOI":"10.14814\/phy2.15490","volume":"22","author":"ES Oh","year":"2022","unstructured":"Oh ES, Steele CN, You Z, Nowak KL, Jovanovich AJ. Sex hormones and the risk of cardiovascular disease and mortality in male and female patients with chronic kidney disease: a systematic review and meta-analysis. Physiol Rep. 2022;22:e15490. https:\/\/doi.org\/10.14814\/phy2.15490.","journal-title":"Physiol Rep"},{"issue":"2","key":"714_CR172","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11255-012-0171-7","volume":"45","author":"M Tanrisev","year":"2013","unstructured":"Tanrisev M, Asci G, Gungor O, Kircelli F, Sevinc Ok E, Yilmaz M, et al. Relation between serum estradiol levels and mortality in postmenopausal female hemodialysis patients. Int Urol Nephrol. 2013;45(2):503\u201310. https:\/\/doi.org\/10.1007\/s11255-012-0171-7.","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"714_CR173","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1093\/ndt\/gfaa126","volume":"35","author":"S Ramesh","year":"2020","unstructured":"Ramesh S, James MT, Holroyd-Leduc JM, Wilton SB, Seely EW, Hemmelgarn BR, et al. Estradiol and mortality in women with end-stage kidney disease. Nephrol Dial Transplant. 2020;35(11):1965\u201372. https:\/\/doi.org\/10.1093\/ndt\/gfaa126.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"714_CR174","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/GME.0000000000000657","volume":"23","author":"S Ramesh","year":"2016","unstructured":"Ramesh S, Mann MC, Holroyd-Leduc JM, Wilton SB, James MT, Seely EW, et al. Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis. Menopause. 2016;23(9):1028\u201337. https:\/\/doi.org\/10.1097\/GME.0000000000000657.","journal-title":"Menopause"},{"issue":"6","key":"714_CR175","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.juro.2007.01.135","volume":"177","author":"NL Miller","year":"2007","unstructured":"Miller NL, et al. Injection, ligation, and transplantation: the search for theglandular fountain of youth. J Urol. 2007;177(6):2000\u20135.","journal-title":"J Urol"},{"key":"714_CR176","doi-asserted-by":"crossref","unstructured":"Medvei VC: A History of Endocrinology, MTP Press, 1982.","DOI":"10.1007\/978-94-009-7304-6"},{"key":"714_CR177","volume-title":"Endocrinology and Metabolism","year":"2001","unstructured":"Felig P, Frohman LA, editors. Endocrinology and Metabolism. 4th ed. New York: McGraw-Hill Inc; 2001.","edition":"4"},{"key":"714_CR178","volume-title":"Williams Textbook of Endocrinology","year":"2015","unstructured":"Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rose CJ, editors. Williams Textbook of Endocrinology. 14th ed. Amsterdam: Elsevier; 2015.","edition":"14"},{"key":"714_CR179","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1476-5381.2012.02036.x","volume":"167","author":"KJ Bubb","year":"2012","unstructured":"Bubb KJ, Khambata RS, Ahluwalia A. Sexual dimorphism in rodent models of hypertension and atherosclerosis. Brit J Pharmacol. 2012;167:298\u2013312.","journal-title":"Brit J Pharmacol"},{"key":"714_CR180","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0039-128X(90)90058-J","volume":"55","author":"MF Kalin","year":"1990","unstructured":"Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids. 1990;55:330\u201352.","journal-title":"Steroids"},{"key":"714_CR181","unstructured":"Kannel WB, and Thom TJ: Incidence, prevalence and mortality and cardiovascular disease, In: The Heart, Schlant RC, Alexander RW, eds, McGraw-Hill, New York, 1994."},{"key":"714_CR182","first-page":"329","volume":"6","author":"KT McGraw-Hill Khaw","year":"1988","unstructured":"McGraw-Hill Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens. 1988;6:329\u201332.","journal-title":"J Hypertens"},{"key":"714_CR183","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0002-8703(88)90099-3","volume":"116","author":"D McGraw-Hill Levy","year":"1988","unstructured":"McGraw-Hill Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J. 1988;116:266\u201372.","journal-title":"Am Heart J"},{"key":"714_CR184","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1210\/er.2003-0005","volume":"24","author":"PY Liu","year":"2003","unstructured":"Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313\u201340.","journal-title":"Endocr Rev"},{"key":"714_CR185","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7326\/0003-4819-107-2-158","volume":"107","author":"FH McGraw-Hill Messerli","year":"1987","unstructured":"McGraw-Hill Messerli FH, Garavaglia GE, Schmieder RE, Sundgaard-Riise K, Nunez BD, Amodeo C. Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med. 1987;107:158\u201361.","journal-title":"Ann Intern Med"},{"key":"714_CR186","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1210\/er.2001-0025","volume":"24","author":"FCW Wu","year":"2003","unstructured":"Wu FCW, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183\u2013217.","journal-title":"Endocr Rev"},{"key":"714_CR187","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/01.ATV.17.10.2004","volume":"17","author":"SM Herman","year":"1997","unstructured":"Herman SM, Robinson JT, McCredie RJ, Adams MR, Boyer MJ, Celermajer DS. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol. 1997;17:2004\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"714_CR188","first-page":"1","volume":"12","author":"SG Mendoza","year":"1983","unstructured":"Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery. 1983;12:1\u201323.","journal-title":"Artery"},{"key":"714_CR189","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/01.HYP.37.5.1199","volume":"37","author":"JF Reckelhoff","year":"2001","unstructured":"Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199\u2013208.","journal-title":"Hypertension"},{"issue":"2","key":"714_CR190","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/01.HYP.31.1.435","volume":"31","author":"JF Reckelhoff","year":"1998","unstructured":"Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension. 1998;31(2):435\u20139.","journal-title":"Hypertension"},{"key":"714_CR191","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/00004872-198909000-00005","volume":"7","author":"U Ganten","year":"1989","unstructured":"Ganten U, Schr\u00f6der G, Witt M, Zimmermann F, Ganten D, Stock G. Sexual Dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen Treatment. J Hypertens. 1989;7:721\u20136.","journal-title":"J Hypertens"},{"key":"714_CR192","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/01.HYP.29.1.494","volume":"29","author":"JT Crofton","year":"1997","unstructured":"Crofton JT, Share L. Gonadal hormones modulate deoxycorticosterone-hypertension in male and female rats. Hypertension. 1997;29:494\u20139.","journal-title":"Hypertension"},{"key":"714_CR193","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.HYP.34.4.920","volume":"34","author":"JF Reckelhoff","year":"1999","unstructured":"Reckelhoff JF, Zhang H, Srivastava H, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats. Role of androgens and androgen receptor. Hypertension. 1999;34:920\u20133.","journal-title":"Hypertension"},{"key":"714_CR194","first-page":"997","volume":"90","author":"SG Iams","year":"1977","unstructured":"Iams SG, Wexler BC. Retardation in the development of spontaneous hypertension in SH rats by gonadectomy. J Lab Clin Med. 1977;90:997\u20131003.","journal-title":"J Lab Clin Med"},{"issue":"5","key":"714_CR195","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/1074248417691136","volume":"22","author":"AM Traish","year":"2017","unstructured":"Traish AM, Haider A, Haider KS, Doros G, Saad F. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Therap. 2017;22(5):414\u201333.","journal-title":"J Cardiovasc Pharmacol Therap"},{"issue":"2","key":"714_CR196","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mayocp.2014.10.011","volume":"90","author":"A Morgentaler","year":"2015","unstructured":"Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224\u201351.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"714_CR197","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.mayocp.2016.04.007","volume":"91","author":"A Morgentaler","year":"2016","unstructured":"Morgentaler A, Zitmann M, Traish AM. Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions. Mayo Clin Proc. 2016;91(7):881\u201396.","journal-title":"Mayo Clin Proc"},{"key":"714_CR198","doi-asserted-by":"publisher","first-page":"R189","DOI":"10.1152\/ajpregu.00110.2015","volume":"309","author":"M Perusquia","year":"2015","unstructured":"Perusquia M, Greenway CD, Perkins LM, Stallone JN. Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent. Am J Physiol, Regul Integ Compar Physiol. 2015;309:R189\u201395.","journal-title":"Am J Physiol, Regul Integ Compar Physiol"},{"key":"714_CR199","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jsbmb.2016.11.016","volume":"167","author":"M Perusquia","year":"2017","unstructured":"Perusquia M, Herrera N, Ferrer M, Stallone JN. Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats. J Steroid Biochem Mol Bio. 2017;167:106\u201314.","journal-title":"J Steroid Biochem Mol Bio"},{"issue":"2","key":"714_CR200","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12020-019-01978-x","volume":"65","author":"M Perusquia","year":"2019","unstructured":"Perusquia M, Contreras D, Herrera N. Hypotestosteronemia is an important factor for the development of hypertension: elevated blood pressure in orchidectomized conscious rats is reversed by different androgens. Endocrine. 2019;65(2):416\u201325.","journal-title":"Endocrine"},{"key":"714_CR201","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13293-020-00324-5","volume":"11","author":"AE Hanson","year":"2020","unstructured":"Hanson AE, Perusquia M, Stallone JN. Hypogonadal hypertension in male Sprague-Dawley rats is renin-angiotensin system-dependent: role of endogenous androgens. Biol Sex Differ. 2020;11:48\u201363.","journal-title":"Biol Sex Differ"},{"key":"714_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115347","volume":"208","author":"JN Stallone","year":"2023","unstructured":"Stallone JN, Oloyo AK. Cardiovascular and metabolic actions of androgens: Is testosterone a Janus-faced molecule? Biochem Pharmacol. 2023;208: 115347.","journal-title":"Biochem Pharmacol"},{"key":"714_CR203","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000176047","volume":"37","author":"JE Nettleship","year":"2009","unstructured":"Nettleship JE, Jones RD, Channer KS, Jones TH. Testosterone and coronary artery disease. Front Horm Res. 2009;37:91\u2013107.","journal-title":"Front Horm Res"},{"key":"714_CR204","doi-asserted-by":"publisher","first-page":"H1301","DOI":"10.1152\/ajpheart.00753.2009","volume":"298","author":"M Perusqu\u00eda","year":"2010","unstructured":"Perusqu\u00eda M, Stallone JN. Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. Am J Physiol, Heart Circ Physiol. 2010;298:H1301\u20137.","journal-title":"Am J Physiol, Heart Circ Physiol"},{"key":"714_CR205","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JOE-12-0582","volume":"217","author":"DM Kelly","year":"2013","unstructured":"Kelly DM, Jones TH. Testosterone: a vascular hormone in health and disease. J Endocrinol. 2013;217:R47\u201371.","journal-title":"J Endocrinol"},{"key":"714_CR206","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1161\/01.CIR.94.10.2614","volume":"94","author":"TM Chou","year":"1996","unstructured":"Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614\u20139.","journal-title":"Circulation"},{"key":"714_CR207","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1113\/jphysiol.2002.022756","volume":"543","author":"C Molinari","year":"2002","unstructured":"Molinari C, Battaglia A, Grossini E, Mary DA, Vassanelli C, Vacca G. The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs. J Physiol. 2002;543:365\u201372.","journal-title":"J Physiol"},{"key":"714_CR208","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1161\/01.CIR.100.16.1690","volume":"100","author":"CM Webb","year":"1999","unstructured":"Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999;100:1690\u20136.","journal-title":"Circulation"},{"issue":"1","key":"714_CR209","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0022-3565(25)12828-0","volume":"277","author":"CE Costarella","year":"1996","unstructured":"Costarella CE, Stallone JN, Rutecki GW, Whittier FC. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther. 1996;277(1):34\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"714_CR210","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2147\/VHRM.S3995","volume":"4","author":"AM Smith","year":"2008","unstructured":"Smith AM, Bennett RT, Jones TH, Cowen ME, Channer KS, Jones RD. Characterization of the vasodilatory action of testosterone in the human pulmonary circulation. Vascular Health and Risk Management. 2008;4:1459\u201366.","journal-title":"Vascular Health and Risk Management"},{"key":"714_CR211","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/BF03346526","volume":"32","author":"KO Rowell","year":"2009","unstructured":"Rowell KO, Hall J, Pugh PJ, Jones TH, Channer KS, Jones RD. Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations. J Endocrinol Invest. 2009;32:718\u201323.","journal-title":"J Endocrinol Invest"},{"key":"714_CR212","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsbmb.2017.11.001","volume":"178","author":"M Perusquia","year":"2018","unstructured":"Perusquia M, Hanson AE, Meza CM, Kubli C, Herrera N, Stallone JN. Antihypertensive responses of vasoactive androgens in an in vivo experimental model of preeclampsia. J Steroid Biochem Molec Biol. 2018;178:65\u201372.","journal-title":"J Steroid Biochem Molec Biol"},{"key":"714_CR213","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1161\/01.ATV.15.5.562","volume":"15","author":"MR Adams","year":"1995","unstructured":"Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Atheroscler Thromb Vasc Biol. 1995;15:562\u201370.","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"714_CR214","first-page":"1","volume":"2011","author":"B Liu","year":"2011","unstructured":"Liu B, Ely D. Testosterone increases sodium reabsorption, blood pressure, and renal pathology in female spontaneously hypertensive rats on a high sodium diet. Adv Pharmacol and Pharm Sci. 2011;2011:1\u20138.","journal-title":"Adv Pharmacol and Pharm Sci"},{"key":"714_CR215","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0735-1097(98)00416-1","volume":"32","author":"RJ McCredie","year":"1998","unstructured":"McCredie RJ, McCrohon JA, Turner L, Griffiths KA, Handelsman DJ, Celermajer DS. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Amer Coll Cardiol. 1998;32:1331\u20135.","journal-title":"J Amer Coll Cardiol"},{"key":"714_CR216","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/sj.jhh.1000481","volume":"11","author":"GB Phillips","year":"1997","unstructured":"Phillips GB, Jing T-Y, Laragh JH. Serum sex hormone levels in postmenopausal women with hypertension. J Hum Hypertens. 1997;11:523\u20136.","journal-title":"J Hum Hypertens"},{"key":"714_CR217","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/01.ATV.17.4.695","volume":"17","author":"GB Phillips","year":"1997","unstructured":"Phillips GB, Pinkernell BH, Jing T-Y. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:695\u2013701.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"714_CR218","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2012.07.005","volume":"224","author":"L Wang","year":"2012","unstructured":"Wang L, Szklo M, Folsom AR, Cook NR, Gapstur SM, Ouyang P. Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women:the multi-ethnic study of atherosclerosis. Atherosclerosis. 2012;224(1):228\u201334.","journal-title":"Atherosclerosis"},{"issue":"3438","key":"714_CR219","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(00)64118-1","volume":"137","author":"CE Brown-Sequard","year":"1889","unstructured":"Brown-Sequard CE. The effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. The Lancet. 1889;137(3438):105\u20137.","journal-title":"The Lancet"},{"key":"714_CR220","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1530\/JOE-12-0455","volume":"217","author":"DM Kelly","year":"2013","unstructured":"Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013;217:R25\u201345.","journal-title":"J Endocrinol"},{"key":"714_CR221","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/hrt.2003.021121","volume":"90","author":"CJ Malkin","year":"2004","unstructured":"Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, Channer KS. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart. 2004;90:871\u20136.","journal-title":"Heart"},{"key":"714_CR222","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1570159X13666141210225414","volume":"13","author":"P Frati","year":"2015","unstructured":"Frati P, Busardo FP, Cipolloni L, Dominicis ED, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13:146\u201359.","journal-title":"Curr Neuropharmacol"},{"key":"714_CR223","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev.pa.33.040193.002433","volume":"33","author":"RW Rockhold","year":"1993","unstructured":"Rockhold RW. Cardiovascular toxicity of anabolic steroids. Ann Rev Pharmacol Toxicol. 1993;33:497\u2013520.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"714_CR224","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/13685539909046290","volume":"2","author":"D Crook","year":"1999","unstructured":"Crook D. Androgen therapy in the aging male: assessing the effect on heart disease. Aging Male. 1999;2:151\u20136.","journal-title":"Aging Male"},{"issue":"2\u20133","key":"714_CR225","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/00224499.2011.558646","volume":"48","author":"EJH Meuleman","year":"2011","unstructured":"Meuleman EJH. Men\u2019s sexual health and the metabolic syndrome. J Sex Research. 2011;48(2\u20133):142\u20138.","journal-title":"J Sex Research"},{"issue":"4","key":"714_CR226","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/oby.21033","volume":"23","author":"G Navarro","year":"2015","unstructured":"Navarro G, Allard C, Xu W, Mauvais-Jarvis F. The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity. 2015;23(4):713\u20139.","journal-title":"Obesity"},{"issue":"10","key":"714_CR227","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/humrep\/deu198","volume":"29","author":"HF Escobar-Morreale","year":"2014","unstructured":"Escobar-Morreale HF, Alvarez-Blasco F, Botella-Carretero JI, Luque-Ramirez M. The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency. Human Reprod. 2014;29(10):2083\u201391.","journal-title":"Human Reprod"},{"key":"714_CR228","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/edrv-14-1-72","volume":"14","author":"C Bouchard","year":"1993","unstructured":"Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev. 1993;14:72\u201393.","journal-title":"Endocr Rev"},{"key":"714_CR229","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/07853899209164140","volume":"24","author":"P Bjorntorp","year":"1992","unstructured":"Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med. 1992;24:15\u20138.","journal-title":"Ann Med"},{"key":"714_CR230","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1210\/jc.2014-2260","volume":"99","author":"ME Wierman","year":"2014","unstructured":"Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, Rosner W, Santoro N. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:3489\u2013510.","journal-title":"J Clin Endocrinol Metab"},{"key":"714_CR231","first-page":"51","volume":"86","author":"C Achard","year":"1921","unstructured":"Achard C, Thiers J. Le virilisme pilaire et son association a l\u2019insuffisance glycolitique (diabete des femmes a barbe). Bull Acad Natl Med Paris. 1921;86:51\u20135.","journal-title":"Bull Acad Natl Med Paris"},{"key":"714_CR232","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"20","author":"J Stein","year":"1935","unstructured":"Stein J, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;20:181\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"714_CR233","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterwei W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038\u201349.","journal-title":"J Clin Endocrinol Metab"},{"key":"714_CR234","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2217\/17455057.4.6.583","volume":"4","author":"CD Christakou","year":"2008","unstructured":"Christakou CD, Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Women\u2019s Health (Lond Eng). 2008;4:583\u201394.","journal-title":"Women\u2019s Health (Lond Eng)"},{"key":"714_CR235","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/dmrr.872","volume":"24","author":"A Corbould","year":"2008","unstructured":"Corbould A. Effects of androgens on insullin action in women: Is androgen excess a component of female metabolic syndrome? Diabetes Metab Res Rev. 2008;24:520\u201332.","journal-title":"Diabetes Metab Res Rev"},{"key":"714_CR236","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-17-0124","volume":"177","author":"L Schiffer","year":"2017","unstructured":"Schiffer L, Kempegowda P, Arit W, O\u2019Reilly MW. The sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol. 2017;177:R125\u201343.","journal-title":"Eur J Endocrinol"},{"key":"714_CR237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-019-0277-z","volume":"11","author":"T Stone","year":"2020","unstructured":"Stone T, Stachenfeld NS. Pathophysiological effects of androgens on the female vascular system. Biol Sex Diff. 2020;11:1\u20138.","journal-title":"Biol Sex Diff"},{"key":"714_CR238","doi-asserted-by":"publisher","first-page":"E576","DOI":"10.1210\/jc.2012-3438","volume":"98","author":"R Montes-Nieto","year":"2013","unstructured":"Montes-Nieto R, Insenser M, Martinez-Garcia MA, Escobar-Morreale HF. A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes. J Clin Endocrinol Metab. 2013;98:E576\u201385.","journal-title":"J Clin Endocrinol Metab"},{"key":"714_CR239","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/EJE-13-1030","volume":"171","author":"A Gambineri","year":"2014","unstructured":"Gambineri A, Fanelli F, Tomassoni F, Munarini A, Pagotto U, Andrew R, Walker BR, Pasquali R. Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 in overweight\/obese women with polycystic ovary syndrome compared with weight-matched controls. Eur J Endocrinol. 2014;171:47\u201357.","journal-title":"Eur J Endocrinol"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-025-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-025-00714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-025-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:04:04Z","timestamp":1747134244000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-025-00714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":239,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1186\/s13293-025-00714-7","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this is review article, this is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}